Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1092, 2006-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
VTE risk included in the new safety information about Evra
Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. :
VTE risk included in the new safety information about Evra
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :
US FDA warns of high estrogen levels with Ortho Evra Patch
Reactions Weekly, Vol. 1, Iss. 1078, 2005-01 ,pp. :
Ximelagatran reduces risk of VTE
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Antipsychotics associated with elevated VTE risk
Reactions Weekly, Vol. 1, Iss. 1321, 2010-01 ,pp. :